Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.632,81
0,35%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Equillium Inc (EQ) Equillium Inc (EQ) Notizie

Equillium Inc

EQ
1,71
-0,10 (-5,52%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/4/202414:00BWEquillium Reports Inducement Grant Under Nasdaq Listing Rule..
01/4/202414:00BWEquillium Announces Positive Topline Data from the Type B..
25/3/202421:01BWEquillium Reports on Fourth Quarter and Full Year 2023..
22/3/202413:00BWEquillium to Present at the H.C. Wainwright Autoimmune &..
08/3/202423:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/3/202422:01EDGAR2Form 8-K - Current report
23/2/202423:12EDGAR2Form 8-K - Current report
23/2/202423:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/2/202412:08EDGAR2Form 8-K - Current report
04/1/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202314:05EDGAR2Form 8-K - Current report
21/12/202314:00BWEquillium Announces Update on Multi-Cytokine Inhibitors..
20/11/202317:23PRNCAEQ Bank Card launches in Québec as Carte Banque EQ
13/11/202315:00BWEquillium Presents Positive Data from Phase 1b EQUALISE..
08/11/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:05EDGAR2Form 8-K - Current report
08/11/202322:01BWEquillium Reports Third Quarter 2023 Financial Results and..
06/11/202314:00BWEquillium Announces Data from Phase 1b EQUALISE Study..
19/10/202314:00BWEquillium Announces Abstracts Accepted for Presentation at..
16/10/202314:05EDGAR2Form 8-K - Current report
16/10/202314:00BWEquillium Announces Preclinical Data from New Orally..
05/10/202323:28EDGAR2Form 8-K - Current report
05/10/202323:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/10/202314:00BWEquillium to Host Analyst & Investor Day
02/10/202314:00BWEquillium to Present at the JonesTrading 2023 Healthcare..
20/9/202314:00BWEquillium to Present at the Cantor Fitzgerald Global..
30/8/202314:00BWEquillium to Attend Wells Fargo Healthcare Conference &..
09/8/202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:06EDGAR2Form 8-K - Current report
09/8/202322:01BWEquillium Reports Second Quarter 2023 Financial Results and..
02/8/202322:00BWEquillium Announces $7.5 Million Share Repurchase Program
01/6/202314:00BWEquillium to Present at the Jefferies Global Healthcare & LD..
15/5/202314:00BWEquillium Announces Poster Presentation at the Annual..
11/5/202322:01BWEquillium Reports First Quarter 2023 Financial Results and..
Apertura: 1,85 Min: 1,69 Max: 1,85
Chiusura: 1,81

La tua Cronologia

NASDAQ
EQ
Equillium
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network